Galectin Therapeutics Inc. (GALT)
NASDAQ·Healthcare·Biotechnology
$2.34
-1.48%
Mkt Cap $215.98M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | $36.32M | — | — | -$0.10 | -$0.08 | +20.00% | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | -$0.11 | -$0.13 | -18.18% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.16 | -$0.12 | +25.00% | — | — |
| Q2 2025 May 15, 2025 | — | — | — | -$0.20 | -$0.15 | +25.00% | — | — |
| Q1 2025 Mar 31, 2025 | — | $36.00K | — | -$0.16 | -$0.19 | -18.75% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.20 | -$0.18 | +10.00% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$0.16 | -$0.20 | -25.00% | — | — |
| Q2 2024 May 15, 2024 | — | — | — | -$0.16 | -$0.19 | -18.75% | — | — |
| Q1 2024 Mar 29, 2024 | — | $80.00K | — | -$0.16 | -$0.16 | +0.00% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.16 | -$0.24 | -50.00% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$0.21 | -$0.15 | +28.57% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$0.21 | -$0.19 | +9.52% | — | — |
| Q1 2023 Mar 30, 2023 | — | — | — | -$0.17 | -$0.18 | -5.88% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$0.20 | -$0.14 | +30.00% | — | — |
| Q3 2022 Aug 15, 2022 | — | — | — | -$0.19 | -$0.16 | +15.79% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | -$0.10 | -$0.17 | -70.00% | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | -$0.19 | -$0.13 | +31.58% | — | — |
| Q4 2021 Nov 15, 2021 | — | — | — | -$0.18 | -$0.14 | +22.22% | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | -$0.18 | -$0.15 | +16.67% | — | — |
| Q2 2021 May 17, 2021 | — | — | — | -$0.17 | -$0.11 | +35.29% | — | — |